
About Salvi Life Science Limited
Data last updated:
Salvi Life Science Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Salvi Chemical Industries Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PLC352620. Its GSTIN is 24ABFCS1768J1Z3 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kaushal Kantilal Salvi and Kantilal Narandas Salvi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 107/108 Western Edge II (Commercial) Off W. E. Highway Borivali (East), Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2024, the company reported a revenue of ₹75,175. For the same year it recorded a net loss of ₹2.3 Lakh (net margin -305.4%) and EBITDA of -₹2.25 Lakh (EBITDA margin -299.9%).
For more details, the company can be reached via its website salvichem.com.
Company details
Contact details
Salvi Life Science Limited's registered office is in Mumbai, Maharashtra. Its website is salvichem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address107/108 Western Edge II (Commercial) Off W. E. Highway Borivali (East), Mumbai, Maharashtra, India – 400066
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Salvi Life Science Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Salvi Life Science is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Salvi Life Science Limited, buy the company report.
Financials of Salvi Life Science Limited
FY 2025 filings availableSalvi Life Science Limited reported revenue of ₹75,175 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.25 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.3 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -299.9% | |||
| Net Profit Margin | -305.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Salvi Life Science Limited, buy the company report.
Board of directors of Salvi Life Science Limited
Salvi Life Science has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaushal Kantilal Salvi | Director | 28 Dec 2020 | 5 Years 10 Months | Current |
| Kantilal Narandas Salvi | Director | 28 Dec 2020 | 5 Years 10 Months | Current |
| Nirav Kantilal Salvi | Director | 28 Dec 2020 | 5 Years 10 Months | Current |
Auditor
Salvi Life Science Limited is audited by KALIDAS S. PATEL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KALIDAS S. PATEL | FY 2023 | 032851 |
Shareholding
The shareholding of Salvi Life Science Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Salvi Life Science Limited, buy the company report.
Legal cases
No court or tribunal cases involving Salvi Life Science Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Salvi Life Science Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Salvi Life Science Limited has 1 active EPFO establishment as of Apr 01, 2024.
GST
Salvi Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24ABFCS1768J1Z3 | Gujarat | Active | 01 Mar 2024 |
To see the full GST registrations and return filing status of Salvi Life Science Limited, buy the company report.
Recent activity
Salvi Life Science Limited has 3 board changes on record since 2020: 3 appointments. The latest: Kantilal Narandas Salvi was appointed as Director on 28 Dec 2020.
Frequently asked questions
Salvi Life Science is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 December 2020 (6+ years old) and is registered under CIN U24290MH2020PLC352620.
Salvi Life Science has 3 current directors:
- Kaushal Kantilal Salvi - Director
- Kantilal Narandas Salvi - Director
- Nirav Kantilal Salvi - Director
The latest financial statements of Salvi Life Science on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Salvi Life Science is 24ABFCS1768J1Z3, registered in Gujarat.
The CIN (Corporate Identification Number) of Salvi Life Science is U24290MH2020PLC352620. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Salvi Life Science was incorporated on 28 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Kantilal Narandas Salvi was appointed as Director on 28 Dec 2020. Kaushal Kantilal Salvi was appointed as Director on 28 Dec 2020. Nirav Kantilal Salvi was appointed as Director on 28 Dec 2020.
Salvi Life Science can be reached through the website salvichem.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Salvi Life Science is at 107108 Western Edge II Commercial Off W. E. Highway Borivali East, Mumbai, Maharashtra, India – 400066.
Salvi Life Science operates in the pharma industry, in the drug formulation and development segment.

